Sonoscape Medical Corp. (300633.SZ) achieved revenue of 1.01 billion in the first half of the year, with significant results in high-end independent innovation.

On the evening of August 28th, Sonoscape Medical Corp. (300633.SZ) disclosed its 2024 interim report. The financial report shows that the company achieved operating income of 1.01 billion yuan, and a net profit of 170 million yuan. The company stated that due to a decrease in purchases by terminal hospitals, the tender volume for ultrasound, endoscopy, and other equipment decreased significantly compared to the same period last year, affecting the company's revenue growth. At the same time, the company maintained a high level of investment intensity in the first half of the year, which had an impact on its short-term performance but provided important support for the company's medium and long-term development. In fact, since 2024, with the advancement of anti-corruption and medical insurance spot checks in the healthcare industry, as well as policies like trade-in programs, medical equipment purchases have become more cautious, leading to a decrease in the use of high-priced low-value consumables. In the first half of 2024, the size of the Chinese medical device market decreased by 3.2% compared to the same period last year. According to publicly disclosed procurement data, the sales of ultrasound equipment in the first half of this year were 6.224 billion yuan, a 39.21% decrease year-on-year, resulting in an overall slowdown in the performance of medical device companies in the first half of the year. In this context, Sonoscape Medical Corp. is firmly promoting a diversified and high-end development strategy, maintaining steady progress in its core business, achieving breakthroughs in innovative business, enhancing operational efficiency, and demonstrating strong developmental resilience. Specifically, in the field of ultrasound business, Sonoscape Medical Corp. focuses on the frontier technology application of "AI + intelligent healthcare," successfully transitioning from...Sonoscape Medical Corp. is increasing investment against the trend, aiming to achieve a strategic layout of exchanging short-term performance for long-term growth. In the future, as the policy of replacing old medical equipment with new ones gradually takes effect, the demand for medical equipment tenders will be released one after another. Sonoscape Medical Corp. is expected to continuously expand market share and steadily increase profitability with its leading technological strength and high-end product line layout.I am tired.